[DPHARMA] QoQ TTM Result on 30-Jun-2013 [#2]

Announcement Date
28-Aug-2013
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2013
Quarter
30-Jun-2013 [#2]
Profit Trend
QoQ- 14.7%
YoY- 8.76%
Quarter Report
View:
Show?
TTM Result
31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 CAGR
Revenue 165,062 162,404 152,048 140,724 137,091 135,311 132,969 15.51%
PBT 42,396 40,177 40,017 39,354 35,384 35,297 34,133 15.56%
Tax -7,243 -6,690 -9,845 -9,526 -9,378 -9,282 -7,787 -4.71%
NP 35,153 33,487 30,172 29,828 26,006 26,015 26,346 21.22%
-
NP to SH 35,153 33,487 30,172 29,828 26,006 26,015 26,346 21.22%
-
Tax Rate 17.08% 16.65% 24.60% 24.21% 26.50% 26.30% 22.81% -
Total Cost 129,909 128,917 121,876 110,896 111,085 109,296 106,623 14.08%
-
Net Worth 190,050 181,818 179,017 187,404 176,143 169,359 167,991 8.58%
Dividend
31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 CAGR
Div 24,289 24,289 20,128 20,128 19,431 19,431 18,318 20.71%
Div Payout % 69.10% 72.53% 66.71% 67.48% 74.72% 74.69% 69.53% -
Equity
31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 CAGR
Net Worth 190,050 181,818 179,017 187,404 176,143 169,359 167,991 8.58%
NOSH 138,723 138,792 138,773 138,818 138,695 138,819 138,836 -0.05%
Ratio Analysis
31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 CAGR
NP Margin 21.30% 20.62% 19.84% 21.20% 18.97% 19.23% 19.81% -
ROE 18.50% 18.42% 16.85% 15.92% 14.76% 15.36% 15.68% -
Per Share
31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 CAGR
RPS 118.99 117.01 109.57 101.37 98.84 97.47 95.77 15.58%
EPS 25.34 24.13 21.74 21.49 18.75 18.74 18.98 21.26%
DPS 17.50 17.50 14.50 14.50 14.00 14.00 13.20 20.70%
NAPS 1.37 1.31 1.29 1.35 1.27 1.22 1.21 8.63%
Adjusted Per Share Value based on latest NOSH - 138,818
31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 CAGR
RPS 17.16 16.88 15.81 14.63 14.25 14.07 13.82 15.53%
EPS 3.65 3.48 3.14 3.10 2.70 2.70 2.74 21.08%
DPS 2.53 2.53 2.09 2.09 2.02 2.02 1.90 21.05%
NAPS 0.1976 0.189 0.1861 0.1948 0.1831 0.1761 0.1746 8.60%
Price Multiplier on Financial Quarter End Date
31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 CAGR
Date 31/03/14 31/12/13 30/09/13 28/06/13 29/03/13 31/12/12 28/09/12 -
Price 3.03 2.58 2.55 2.38 2.23 2.13 2.36 -
P/RPS 2.55 2.20 2.33 2.35 2.26 2.19 2.46 2.42%
P/EPS 11.96 10.69 11.73 11.08 11.89 11.37 12.44 -2.59%
EY 8.36 9.35 8.53 9.03 8.41 8.80 8.04 2.63%
DY 5.78 6.78 5.69 6.09 6.28 6.57 5.59 2.25%
P/NAPS 2.21 1.97 1.98 1.76 1.76 1.75 1.95 8.71%
Price Multiplier on Announcement Date
31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 CAGR
Date 20/05/14 26/02/14 19/11/13 28/08/13 27/05/13 25/02/13 23/11/12 -
Price 3.09 2.60 2.56 2.44 2.51 2.17 2.28 -
P/RPS 2.60 2.22 2.34 2.41 2.54 2.23 2.38 6.07%
P/EPS 12.19 10.78 11.77 11.36 13.39 11.58 12.01 0.99%
EY 8.20 9.28 8.49 8.81 7.47 8.64 8.32 -0.96%
DY 5.66 6.73 5.66 5.94 5.58 6.45 5.79 -1.50%
P/NAPS 2.26 1.98 1.98 1.81 1.98 1.78 1.88 13.07%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ & YoY figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment